CCR5 inhibition in colorectal cancer patients

被引：3
|
作者：
Halama, Niels [1 ]
机构：
[1] Univ Heidelberg Hosp, Dept Med Oncol & Internal Med 6, Natl Ctr Tumor Dis, Heidelberg, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷
关键词：
IMMUNOTHERAPY; RECEPTOR; THERAPY; TARGET;
D O I：
10.21037/tcr.2016.07.42
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S366 / S367
页数：2
相关论文
共 50 条
  • [1] CCR5 inhibition: macrophage repolarization therapy for colorectal cancer
    Halama, Niels
    Zoernig, Inka
    Berthel, Anna
    Kahlert, Christoph
    Klupp, Fee
    Suarez-Carmona, Meggy
    Brand, Karsten
    Krauss, Juergen
    Lasitschka, Felix
    Ulrich, Alexis
    Weitz, Juergen
    Schneider, Martin
    Buechler, Markus
    Zitvogel, Laurence
    Herrmann, Thomas
    Benner, Axel
    Kunz, Christina
    Luecke, Stephan
    Springfeld, Christoph
    Falk, Christine S.
    Jaeger, Dirk
    CANCER RESEARCH, 2017, 77
  • [2] Macrophage repolarization therapy in metastatic colorectal cancer: CCR5 inhibition
    Halama, Niels
    Zoernig, Inka
    Berthel, Anna
    Kahlert, Christoph
    Klupp, Fee
    Suarez-Carmona, Meggy
    Krauss, Juergen
    Brand, Karsten
    Lasitschka, Felix
    Lerchl, Tina
    Luckner-Minden, Claudia
    Ulrich, Alexis
    Weitz, Juergen
    Schneider, Martin
    Buechler, Markus W.
    Zitvogel, Laurence
    Herrmann, Thomas
    Benner, Axel
    Kunz, Christina
    Luecke, Stephan
    Springfeld, Christoph
    Falk, Christine
    Jaeger, Dirk
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [3] Inhibition and blockage of CCR5: A possible therapeutic option for colorectal cancer
    Pervaiz, A.
    Berger, M. R.
    Adwan, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 44 - 44
  • [4] CCR5 and CCL5 in metastatic colorectal cancer
    Schlechter, Benjamin L.
    Stebbing, Justin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)
  • [5] The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer
    Ward, S. T.
    Li, K. K.
    Hepburn, E.
    Weston, C. J.
    Curbishley, S. M.
    Reynolds, G. M.
    Hejmadi, R. K.
    Bicknell, R.
    Eksteen, B.
    Ismail, T.
    Rot, A.
    Adams, D. H.
    BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 319 - 328
  • [6] The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer
    S T Ward
    K K Li
    E Hepburn
    C J Weston
    S M Curbishley
    G M Reynolds
    R K Hejmadi
    R Bicknell
    B Eksteen
    T Ismail
    A Rot
    D H Adams
    British Journal of Cancer, 2015, 112 : 319 - 328
  • [7] CCR5 status and metastatic progression in colorectal cancer
    Suarez-Carmona, Meggy
    Chaorentong, Pornpimol
    Kather, Jakob Nikolas
    Rothenheber, Rebecca
    Ahmed, Azaz
    Berthel, Anna
    Heinzelmann, Anita
    Moraleda, Rodrigo
    Valous, Nektarios A.
    Kosaloglu, Zeynep
    Eurich, Rosa
    Wolf, Jana
    Grauling-Halama, Silke
    Hundemer, Michael
    Lasitschka, Felix
    Klupp, Fee
    Kahlert, Christoph
    Ulrich, Alexis
    Schneider, Martin
    Falk, Christine
    Jaeger, Dirk
    Zoernig, Inks
    Halama, Niels
    ONCOIMMUNOLOGY, 2019, 8 (09):
  • [8] CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
    Gonzalez-Martin, Alicia
    Mira, Emilia
    Manes, Santos
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (09) : 1045 - 1057
  • [9] CCR5 antagonist, an ally to fight against metastatic colorectal cancer
    Mukaida, Naofumi
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S309 - S312
  • [10] The role of CCR5 polymorphism in colorectal cancer and liver metastasis in the Tunisian population
    Weslati, Marwa
    Boughriba, Rahma
    Ounissi, Donia
    Hazgui, Meriam
    Marghali, Sonia
    ARCHIVES OF BIOLOGICAL SCIENCES, 2021, 73 (04) : 503 - 512
12345